openPR Logo
Press release

Candidiasis Market to Surpass US$ 1,307.2 Million by 2026 | Astellas Pharma Inc., Grupo Ferrer Internacional, S.A., Pacgen Life Science Corporation

08-12-2020 02:16 PM CET | Health & Medicine

Press release from: Coherent Market Insights (CMI)

Candidiasis Market

Candidiasis Market

Increasing adoption of inorganic growth strategies such as mergers and acquisitions for the development of novel drugs by market players is expected to propel the market growth. For instance, in March 2018, NovaQuest Capital Management L.L.C. acquired Viamet Pharmaceuticals (NC), Inc., which included the company's product candidate, VT-1161, which successfully completed Phase 2b clinical trials. The product is indicated for the treatment of recurrent vulvovaginal candidiasis and onychomycosis (fungal nail infection). Moreover, in 2014, NovaDigm Therapeutics acquired the rights to three Candida vaccine antigens from the Los Angeles BioMedical Research Institute at Harbor-UCLA Medical Center, which significantly strengthened the company's candida vaccine pipeline.

Request a sample report @ https://www.coherentmarketinsights.com/insight/request-sample/229

The market is expected to register significant growth as various research institutes are focused on developing novel drug combinations to enhance drug efficacy. For instance, in June 2019, microbiologists at the Beth Israel Deaconess Medical Center (BIDMC) demonstrated that combination of anti-fungal and anti-bacterial medications can effectively target multidrug resistant Candida auris. Similarly in October 2018, researchers at the American Society for Microbiology identified a compound alexidine dihydrochloride, which has the highest antifungal and anti-biofilm activity against a diverse range of fungal pathogens, thus having a greater potential for use as a pan-antifungal drug.

Key Players

Major players operating in the global candidiasis market include, Basilea Pharmaceutica Ltd., Astellas Pharma Inc., Grupo Ferrer Internacional, S.A., Pacgen Life Science Corporation, NovaDigm Therapeutics, Inc., Cidara Therapeutics, Inc., Amplyx Pharmaceuticals Inc., and Pfizer, Inc.

Key Developments

Major institutes and universities are focused on R&D activities related to candidiasis. For instance, on September 09, 2019, a team of researchers from Southmead Hospital, Bristol, in collaboration with Triticum Exploitatie B.V., tested the vulnerability of Candida albicans to honey and an MGH formulation (L-Mesitran) by evaluating five isolates from vaginal samples of symptomatic patients suffering from recurrent vulvovaginal candidiasis.

In August 2019, researchers from Complutense University of Madrid developed fast-dissolving orodispersible films of amphotericin B for oropharyngeal candidiasis.

Download PDF brochure of this report @ https://www.coherentmarketinsights.com/insight/request-pdf/229

In July 2019, researchers from Instituto de Química Rosario, Argentina, designed chitosan nanoformulations for the delivery of antifungal agents. The approach can aid in the development of a pharmaceutical dosage form suitable for the treatment of vaginal candidiasis.

Coherent Market Insights 1001 4th Ave,
#3200 Seattle, WA 98154,U.S.
Phone: US +1-206-701-6702/UK +44-020 8133 4027
Email: sales@coherentmarketinsights.com

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Candidiasis Market to Surpass US$ 1,307.2 Million by 2026 | Astellas Pharma Inc., Grupo Ferrer Internacional, S.A., Pacgen Life Science Corporation here

News-ID: 2110737 • Views: 398

More Releases from Coherent Market Insights (CMI)

What Will Be Driving Growth of Feminine Hygiene Products market Near Future By T …
Latest Report Available Coherent Market Insights at , “Feminine Hygiene Products Market” provides pin-point analysis for changing competitive dynamics and a forward looking perspective on different factors driving or restraining industry growth. The global Feminine Hygiene Products market focuses on encompassing major statistical evidence for the Feminine Hygiene Products industry as it offers our readers a value addition on guiding them in encountering the obstacles surrounding the market. A comprehensive addition
Trending now: Well Intervention Market Share, Growth, Demand, Trends, Region Wis …
Latest Report Available Coherent Market Insights at , “Well Intervention Market” provides pin-point analysis for changing competitive dynamics and a forward looking perspective on different factors driving or restraining industry growth. The global Well Intervention market focuses on encompassing major statistical evidence for the Well Intervention industry as it offers our readers a value addition on guiding them in encountering the obstacles surrounding the market. A comprehensive addition of several factors
Waste to Energy Market Segmentation By Qualitative And Quantitative Research Inc …
Latest Report Available Coherent Market Insights at , “Waste to Energy Market” provides pin-point analysis for changing competitive dynamics and a forward looking perspective on different factors driving or restraining industry growth. The global Waste to Energy market focuses on encompassing major statistical evidence for the Waste to Energy industry as it offers our readers a value addition on guiding them in encountering the obstacles surrounding the market. A comprehensive addition
Termite Control Market | Know the Companies List Could Potentially Benefit or Lo …
Latest Report Available Coherent Market Insights at , “Termite Control Market” provides pin-point analysis for changing competitive dynamics and a forward looking perspective on different factors driving or restraining industry growth. The global Termite Control market focuses on encompassing major statistical evidence for the Termite Control industry as it offers our readers a value addition on guiding them in encountering the obstacles surrounding the market. A comprehensive addition of several factors

All 5 Releases


More Releases for Candidiasis

Candidiasis Epidemiology Insights to 2025
Publisher " Candidiasis - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Candidiasis in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Candidiasis prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with
Candidiasis Therapeutic and Disease Pipeline Review H1
Summary Candidiasis is caused by infection with species of the genus Candida, predominantly with Candida albicans. A Candida infection of the skin appears as a clearly defined patch of red, itchy skin, often leaking fluid. Scabs and pustules may be seen around the edge of the rash. It will usually be found in areas such as the groin, the folds of the buttocks, between the breasts, toes, or fingers, and in
Develop business strategies Of Candidiasis - Pipeline Review, H1 2018
"The Report Candidiasis - Pipeline Review, H1 2018 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Candidiasis Market Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Candidiasis - Pipeline Review, H1 2018, provides an overview of the Candidiasis (Infectious Disease) pipeline landscape. Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1581036 Candidiasis is caused by infection with species of the
Candidiasis - Pipeline Review, H2 2017
Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Candidiasis - Pipeline Review, H2 2017, provides an overview of the Candidiasis (Infectious Disease) pipeline landscape. Candidiasis is caused by infection with species of the genus Candida, predominantly with Candida albicans. A Candida infection of the skin appears as a clearly defined patch of red, itchy skin, often leaking fluid. Scabs and pustules may be seen around the edge of the
Candidiasis - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Candidiasis - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Candidiasis - Pipeline Review, H1 2017, provides an overview of the Candidiasis (Infectious Disease) pipeline landscape. Candidiasis is caused by infection with species of the genus Candida, predominantly with Candida albicans. A Candida infection of the skin
Candidiasis Market - Global Industry Analysis 2024
Candidiasis is a type of infection caused due to candida—an yeast and also classified as fungus, which is present in the human body. It is usually present in places like mouth, belly, and on the skin. The overgrowth of these leads to an infection. This dormant yeast can lead to candida infection at any stage in a person’s life and is closely linked to the immunity level of the person.